Triple Jump Overview
Triple Jump Israel is currently developing an innovative small insulin pump patch for patients with diabetes. Designed to be placed on the patients body, the patch has mobile connectivity capabilities and will be included in a future artificial pancreas system. The Triple Jump system comprises a compact, fully portable, battery-operated miniature insulin pump and hand-held controller. It includes all supporting accessories and sterile single-use disposables.
Cumulative Funding Raised Over Time ($)
$20.0MSep 2020
Latest News
growth-positive
Medtronic in talks to buy Israeli co Triple Jump for $300m
Medtronic plans to acquire Triple Jump, an Israeli insulin pump patch developer, at a company valuation of $300 million. Triple Jumps insulin pump patch will be integrated into Medtronics artificial pancreas system to enhance its pumping capabilities. The patch is designed to be placed on the patients body and has mobile connectivity capabilities. Medtronic had previously invested $20 million in Triple Jump and now plans to acquire the full holdings. The acquisition is expected to contribute to Medtronics growth in the medical devices market.
Acquisition
growth-positive
Medtronic investing $20 million in Israeli insulin pump startup Triple Jump
Medical device giant Medtronic has invested $20 million in Israeli startup Triple Jump, with the option to acquire the entire company. Triple Jump is developing a small insulin pump patch with mobile connectivity capabilities, which will be included in a future artificial pancreas system. Medtronic previously invested $4.5 million in BioProtect, an Israeli company developing a product to protect prostate cancer patients undergoing radiation therapy. Triple Jumps additional investors include Elixir Medical Corporation, Wealth Strategy Holding, and Dov Moran. Medtronic has previously acquired other Israeli companies, including Nutrino and Mazor Robotics.
Investment
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $20M |
| Last funding | $20M |
| Stage | Seed |
| Rounds | 1 |
| Investors | 4 |
Team Members
3
Employees: 11-50
Web & Social Links
Locations
HaCarmel Street 5, Yokne'am Illit, Israel
Photos & Videos
No files yet
Triple Jump Business
Business models
B2B
Product stage
R&D
Employees
11-50
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryMedical DevicesMedical Treatment & TherapeuticsTarget Customer
Healthcare & Life SciencesHealthcarePatientsCore Technology
CommunicationsTags (9)
drug-deliverymedical-devicestype-2-diabetesdiabetesconnectivitybluetoothmonitoringpatent-pendingpumpsTriple Jump Financials
$20M
Total funding
Undisclosed
Capital raised
$20M
Last funding
Seed
Funding stage
1
Total rounds
4
Investors
Cumulative Funding Raised Over Time ($)
$20.0MSep 2020
Private Equity Funding
Undisclosed Round
Sep 2020
$20M
Medtronic (Lead)
,
Dov Moran, Wealth Strategy Holding , Elixir Medical Corporation
Triple Jump Lifecycle
Cumulative Funding Raised Over Time
$20.0MSep 2020
All Events
Undisclosed Round
Sep 2020
$20M
Medtronic (Lead)
,
Dov Moran, Wealth Strategy Holding , Elixir Medical Corporation
Triple Jump News
2 articles
growth-positive
Medtronic in talks to buy Israeli co Triple Jump for $300m
Medtronic plans to acquire Triple Jump, an Israeli insulin pump patch developer, at a company valuation of $300 million. Triple Jumps insulin pump patch will be integrated into Medtronics artificial pancreas system to enhance its pumping capabilities. The patch is designed to be placed on the patients body and has mobile connectivity capabilities. Medtronic had previously invested $20 million in Triple Jump and now plans to acquire the full holdings. The acquisition is expected to contribute to Medtronics growth in the medical devices market.
Acquisition
growth-positive
Medtronic investing $20 million in Israeli insulin pump startup Triple Jump
Medical device giant Medtronic has invested $20 million in Israeli startup Triple Jump, with the option to acquire the entire company. Triple Jump is developing a small insulin pump patch with mobile connectivity capabilities, which will be included in a future artificial pancreas system. Medtronic previously invested $4.5 million in BioProtect, an Israeli company developing a product to protect prostate cancer patients undergoing radiation therapy. Triple Jumps additional investors include Elixir Medical Corporation, Wealth Strategy Holding, and Dov Moran. Medtronic has previously acquired other Israeli companies, including Nutrino and Mazor Robotics.
Investment
Triple Jump Team
Employee Info
| Employees (range) | 11-50 |
| Exact count | 14 |
| Team members | 3 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 9 classification IDs that could be used for matching.
Triple Jump Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 85/100 |
| Missing | homepage, video or image, markets, not claimed |
| BI Verification | Yotam Maman |
| Registrar ID | 515235646 |
| Crunchbase | triple-jump-medical |
| Phone | +972737079070 |
| Creator | Yanina Wainscheinker |
| Creator email | yanina.wain@gmail.com |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wainscheinker@sncentral.org |
| Last update | 2022-11-16T00:00:00.000Z |
| Created | 2020-09-23T00:00:00.000Z |